ArticleChemical communications (Cambridge, England)2012
A nanoscale graphene oxide-peptide biosensor for real-time specific biomarker detection on the cell surface.
Article in Chemical communications (Cambridge, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 109 citations in OpenAlex.
- The Role and Future of Functional Graphenic Materials in Biomedical and Human Health Applications.Biomacromolecules · 2025Review
- In Vitro Detection of Lactate and Uric Acid Based on Adaptive Graphene Oxide Membranes.Small science · 2024Article
- Graphene-Based Biosensors for Molecular Chronic Inflammatory Disease Biomarker Detection.Biosensors · 2022Review
- Graphene and graphene oxide with anticancer applications: Challenges and future perspectives.MedComm · 2022Review
- Article
- Functionalization of Metal and Carbon Nanoparticles with Potential in Cancer Theranostics.Molecules (Basel, Switzerland) · 2021Review
- Graphene Oxide-Based Nanomaterials: An Insight into Retinal Prosthesis.International journal of molecular sciences · 2020Review
- Graphene Nanomaterials-Based Radio-Frequency/Microwave Biosensors for Biomaterials Detection.Materials (Basel, Switzerland) · 2019Review
- Biomedical Applications of Graphene-Based Structures.Nanomaterials (Basel, Switzerland) · 2018Review
- Graphene and its derivatives as biomedical materials: future prospects and challenges.Interface focus · 2018Review
- Thermal and aqueous stability improvement of graphene oxide enhanced diphenylalanine nanocomposites.Science and technology of advanced materials · 2017Article
- Graphene-based nanomaterials for bioimaging.Advanced drug delivery reviews · 2016Review
- Graphene: The Missing Piece for Cancer Diagnosis?Sensors (Basel, Switzerland) · 2016Review
- Development of individualized anti-metastasis strategies by engineering nanomedicines.Chemical Society reviews · 2015Review
- Surface Functionalization of Chemically Reduced Graphene Oxide for Targeted Photodynamic Therapy.Journal of biomedical nanotechnology · 2015Article
- Bioinspired nanocomplex for spatiotemporal imaging of sequential mRNA expression in differentiating neural stem cells.ACS nano · 2014Article
- A symmetrical fluorous dendron-cyanine dye-conjugated bimodal nanoprobe for quantitative 19F MRI and NIR fluorescence bioimaging.Advanced healthcare materials · 2014Article
- Dual-factor triggered fluorogenic nanoprobe for ultrahigh contrast and subdiffraction fluorescence imaging.Biomaterials · 2013Article
- DNA-guided metal-nanoparticle formation on graphene oxide surface.Advanced materials (Deerfield Beach, Fla.) · 2013Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
Abstract
A nanoscale RGD-pyrene-graphene oxide (GO) biosensor was prepared for real-time in situ detection of a cancer cell surface marker, integrin αvβ3. This nanoscale GO-based biosensor is simple, robust, sensitive and of high selectivity. It can also be adapted to other cancer cell surface marker evaluation systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.